American Journal of Psychiatry

Papers
(The H4-Index of American Journal of Psychiatry is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?442
Broadening the Parameters of Clinical High Risk for Psychosis418
2024 Annual Meeting: Presidential Address332
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?183
Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology176
Evaluating Associations Between Cannabis and Heroin Use168
Treating Pathologies of the Will146
Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia130
Mental Health Disparities Research: An Introduction to New Directions126
Highlights From the Residents’ Journal: December 2021112
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies?102
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial102
A New Agenda for Optimizing Investments in Community Mental Health and Reducing Disparities100
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosi98
COVID-19 and Stress-Related Disorders96
A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now94
On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide86
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis85
Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma85
Intentional Drug Overdose Deaths in the United States83
Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments80
Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders78
The First Large GWAS Meta-Analysis for Postpartum Depression76
Coordinate Network Mapping: An Emerging Approach for Morphometric Meta-Analysis75
Whole Brain White Matter Tract Deviation and Idiosyncrasy From Normative Development in Autism and ADHD and Unaffected Siblings Link With Dimensions of Psychopathology and Cognition75
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials75
Trends in Prescription Stimulant, Opioid, and Benzodiazepine Use and Diversion in U.S. Adolescents74
Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population74
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden73
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression71
2024 Annual Meeting: CEO and Medical Director’s Address67
Highlights From the Residents’ Journal: September 202166
Correcting Overestimations in Self-Harm Visit Data66
APA Council Reports65
Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder64
Highlights From the Residents’ Journal: September 202464
12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use63
Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek63
Correction to Poirot et al.62
Corrigendum to Morley et al.60
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression57
Neural Responses to Intranasal Oxytocin in Youths With Severe Irritability56
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.55
Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia54
Suicide and the Menstrual Cycle54
New Insights Into Psychotic Disorders54
Early Adversity and Development: Parsing Heterogeneity and Identifying Pathways of Risk and Resilience53
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial50
The Neglected Role of Psychotherapy for Treatment-Resistant Depression48
Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank48
Risk of Incident Psychosis and Mania With Prescription Amphetamines48
Aberrant Developmental Patterns of Gamma-Band Response and Long-Range Communication Disruption in Youths With 22q11.2 Deletion Syndrome48
Alcohol and the Etiology of Depression48
0.36369609832764